Asthmatx Breathes Easier

Four-year old Asthmatx aims to be the first device company in asthma, a multi-billion dollar drug market. Asthmatx has run its Alair device, which reduces smooth muscle in the lung, through several clinical trials with an eye toward giving a choice to people suffering from the severest forms of the disease.

Tom Salemi

The success stories from Asthmatx Inc. ’s many clinical trials may sound more mundane than miraculous. But for people with...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from In Vivo Archive

More from In Vivo